Meta Pixel

News and Announcements

Adelaide Startup Secures Pre-Seed for Proof of Concept

  • Published July 21, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
Superbucks, has successfully closed off their Pre-Seed round and ready for their next phase of development for their Proof of Concept.

Mindvision, also based in Adelaide, has been commissioned to build locally the application and features needed to showcase the service to prospective investors interested in taking part in the virtual horse ownership scene.

In addition, Superbucks has obtained a data supply contract. This valuable data will fuel and visualise the gains over the past year by using the Superbucks algorithm and engine.

Additional updates will be provided over the coming weeks through the Wholesale Investor network. Be sure to follow the company or request access via CRIISP to stay updated.

Register Interest

About Superbucks Pty Ltd

Starting with as little as 1000 Superpoints the customer can invest in any horse that is nominated for a TAB meeting. Each horse is allocated 1000 lots which are available to the customer to purchase and they may choose any amount of lots from 1-1000 if available and purchase with their superpoints.

Once the customer has purchased lots on a horse or horses, they are able to sit back and follow their horse’s campaign and grow their superpoints from any prize money, odds or trade.

The customer may hold their lots or trade their lots with other punters and re-invest in other horses or simply exchange their superpoints for the ultimate superbuck cash exchange into their investment account.

Superpoints are the currency used to invest, buy, trade and win. Simply load a minimum of $10 on to your account and exchange to your Superpoints ($10 = 1000 Superpoints).

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now